Yichang Humanwell Pharmaceutical Co., Ltd

The 2023 pharmaceutical sales ranking of the top 100 Asian biopharma firms reveals a mix of company-specific and wider performance factors linked to both individual corporate fortunes and the changing

Paion is set to learn this week whether the European Medicines Agency will recommend pan-EU marketing approval for remimazolam, its ultra-short-acting intravenous benzodiazepine for use in procedural